ACCA · Question 23 · Estimating the Cost of Capital
Section B - Case 2: NeuroLink Prosthetics
Scenario: NeuroLink Prosthetics is a MedTech firm. It has 10 million ordinary shares in issue, currently trading at $4.50 per share. The company's equity beta is 1.2. The risk-free rate of return is 4% and the expected return on the market portfolio is 10%. NeuroLink also has $15 million (nominal value) of 6% redeemable bonds, currently trading at $95 per $100 nominal, redeemable at par in 5 years. The corporate tax rate is 25%.
Assume the cost of equity (Ke) is 11.2% and the after-tax cost of debt (Kd) is 5.7%.
Question: What is NeuroLink's Weighted Average Cost of Capital (WACC) based on market values?
Answer options:
8.45%
9.88%
10.12%
11.20%
32 questions · hints · full answers · grading